ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 663

$694K Total Retail Price of All Prescriptions

Rank: 28 out of 663

377 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 377 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

18% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,112 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LISINOPRIL 535 515 1 2
LEVOTHYROXINE SODIUM 460 453 2 3
HYDROCODONE-ACETAMINOPHEN 278 246 S3 3 6
AMLODIPINE BESYLATE 274 273 4 5
ATORVASTATIN CALCIUM 255 251 5 13
SIMVASTATIN 219 207 6 1
TRAZODONE HCL 218 207 7 34
ALLOPURINOL 215 215 8 28
OMEPRAZOLE 214 197 9 4
POTASSIUM CHLORIDE 187 187 10 23
NAMENDA 169 169 11 57
RANITIDINE HCL 165 157 12 31
ATENOLOL 164 164 13 10
WARFARIN SODIUM 164 162 13 8
PANTOPRAZOLE SODIUM 152 145 15 45
DONEPEZIL HCL 152 152 15 40
CYMBALTA 133 105 17 54
FUROSEMIDE 128 127 18 7
FLUOXETINE HCL 127 114 19 32
PRAVASTATIN SODIUM 110 110 20 21
GLIPIZIDE ER 107 107 21 130
SERTRALINE HCL 101 92 22 35
METOPROLOL SUCCINATE 95 92 23 25
NEXIUM 95 91 23 43
METFORMIN HCL 92 62 25 9
DOXAZOSIN MESYLATE 92 92 25 73
BUMETANIDE 91 91 27 110
DIGOXIN 89 89 28 50
LOVASTATIN 84 71 29 30
EXELON 80 80 30 172
PREDNISONE 79 76 31 39
OXYCODONE HCL 76 75 S2 32 41
AMITRIPTYLINE HCL 74 74 R 33 95
CYCLOBENZAPRINE HCL 72 63 R 34 71
LOSARTAN POTASSIUM 72 69 34 14
GLIPIZIDE 71 61 36 29
OXYCONTIN 71 71 S2 36 98
GABAPENTIN 71 46 36 20
FENTANYL 69 59 S2 39 75
DIOVAN 69 67 39 59
HYDROCHLOROTHIAZIDE 68 64 41 12
LANTUS 64 64 42 48
FELODIPINE ER 63 63 43 114
LEVOXYL 63 49 43 133
ISOSORBIDE MONONITRATE ER 62 62 45 93
MIRTAZAPINE 62 62 45 52
OXYCODONE-ACETAMINOPHEN 61 51 S2 47 26
AZITHROMYCIN 60 54 48 64
TAMSULOSIN HCL 60 60 48 24
POLYETHYLENE GLYCOL 3350 58 58 50 82
CARBIDOPA-LEVODOPA 57 51 51 102
CLOPIDOGREL 55 55 52 65
HUMALOG 55 55 52 194
CRESTOR 55 53 52 37
KLOR-CON M20 52 52 55 70
COLCRYS 52 52 55 324
NIASPAN 51 47 57 117
SYNTHROID 50 50 58 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.